-
Quest Diagnostics Reveals Planned Senior Notes Offering For $500M
Monday, May 23, 2016 - 2:18pm | 165Read More...Quest Diagnostics Inc (NYSE: DGX) revealed that it plans to offer $500 million aggregate principal amount of senior notes in a public offering. The company indicated that the issuance of the notes would be subject to customary closing conditions. Related Link: Chardan Initiates Asterias...
-
Mizuho Puts $37 Billion Value on eBay's Standalone Business
Wednesday, August 19, 2015 - 12:03pm | 274Read More...On July 17, eBay Inc (NASDAQ: EBAY) spun off its Paypal Holdings Inc (NASDAQ: PYPL) unit into a separate public company, sending analysts scrambling to fill in the blanks. One piece of the puzzle was just filled when eBay released 8-K filings that provided the standalone company's historical...
-
Mizuho Updates Macro & Rate Outlook, 3 Health Care REITs To Buy
Wednesday, May 27, 2015 - 1:11pm | 1007Read More...On Tuesday, Mizuho Securities USA released a note updating the U.S. REIT sector based upon macro views on the economy and interest rates by its Chief Economist Steve Ricchiuto. The Mizuho outlook suggests that the 'Fed Lift-Off' will be "pushed back to 2016," and the 10-Year Treasury to remain in...
-
Mizuho Securities Analyst: Apple Watch Is Going To Have Hard Time Filling iPhone Tech Gap
Monday, February 23, 2015 - 3:16pm | 422Read More...Apple Inc. (NASDAQ: AAPL) is continuing the bull run it started post its fourth-quarter results declaration, surpassing the $750 billion market cap mark on Monday. However, according to Mizuho Securities analyst Abhey Lamba, a lot of good news regarding sales of the iPhone and the Apple Watch are...
-
UPDATE: Mizuho Securities Reiterates On Auxilium Pharmaceuticals On Cost Savings/Taxes
Wednesday, September 17, 2014 - 10:10am | 129Read More...In a report published Wednesday, Mizuho Securities analyst Mario Corso reiterated a Buy rating on Auxilium Pharmaceuticals (NASDAQ: AUXL), and raised the price target from $33.00 to $37.00. In the report, Mizuho Securities USA noted, “Last night's ENDP bid of $28.10/AUXL share is below 2014 high...
-
Mizuho Securities USA Believes Acquisition Potential Is Likely Overstated For TIBCO Software Inc.
Tuesday, September 16, 2014 - 11:17am | 142Read More...In a report published Tuesday, Mizuho Securities USA analyst Abhey Lamba reiterated a Neutral rating and $18.00 price target on TIBCO Software Inc. (NASDAQ: TIBX). In the report, Mizuho Securities USA noted, “TIBCO will report its results on Thursday after the close. We expect revenues and EPS to...
-
UPDATE: Mizuho Securities USA Initiates Coverage On Epizyme Inc On Epigenetics Pure Play
Friday, September 12, 2014 - 9:39am | 114Read More...In a report published Friday, Mizuho Securities USA analyst Peter Lawson initiated coverage on Epizyme Inc (NASDAQ: EPZM) with a Buy rating and $35.00 price target. In the report, Mizuho Securities USA noted, “We are initiating coverage of shares of Epizyme with a Buy rating and a price target of $...
-
UPDATE: Mizuho Securities USA Initiates Coverage On NewLink Genetics Corp On Emerging Market Pure Play
Friday, September 12, 2014 - 9:33am | 106Read More...In a report published Friday, Mizuho Securities USA analyst Peter Lawson initiated coverage on NewLink Genetics Corp (NASDAQ: NLNK) with a Buy rating and $50.00 price target. In the report, Mizuho Securities USA noted, “We are initiating coverage of shares of NewLink Genetics with a Buy rating and...
-
Mizuho Securities USA Sees Solid Underlying Business Trends For CVS Caremark
Monday, May 5, 2014 - 8:15am | 121Read More...In a report published Monday, Mizuho Securities USA analyst Ann Hynes reiterated a Buy rating and $81.00 price target on CVS Caremark (NYSE: CVS). In the report, Mizuho Securities USA noted, “We reiterate our Buy rating and $81 price target after a solid 1Q. Upside in the PBM helped offset...
-
Mizuho Securities USA Lowers Revenue Outlook on Motorola Solutions
Wednesday, April 16, 2014 - 7:50am | 131Read More...In a report published Wednesday, Mizuho Securities USA analyst Matthew Hoffman reiterated a Neutral rating and $63.00 price target on Motorola Solutions (NYSE: MSI). In the report, Mizuho Securities USA noted, “Motorola Solutions lowered its full year and 1Q14 revenue outlook BMO 4/15, and...
-
Mizuho Securities USA Feels Confident in Informatica Ahead of 1Q14 Results
Wednesday, April 16, 2014 - 7:49am | 135Read More...In a report published Wednesday, Mizuho Securities USA analyst Abhey Lamba reiterated a Buy rating and $50.00 price target on Informatica (NASDAQ: INFA). In the report, Mizuho Securities USA noted, “INFA will report results on April 24. We expect results to be slightly ahead of the upper end of...
-
Mizuho Securities Reiterates Buy on Questcor Pharmaceuticals on Stock Price Weakness
Tuesday, November 26, 2013 - 11:59am | 116Read More...In a report published Tuesday, Mizuho Securities USA analyst Mario Corso reiterated a Buy rating and $93.00 price target on Questcor Pharmaceuticals (NASDAQ: QCOR). In the report, Mizuho Securities USA noted, “In the wake of today's stock price weakness on short report that FTC will challenge...
